Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Tisch Cancer Institute | Researchclopedia

Back to institutions

Tisch Cancer Institute

New Yorkhealthcare

1,006

Works

95,149

Citations

148

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Bladder and Urothelial Cancer Treatments Multiple Myeloma Research and Treatments

Top Researchers

Carlo La Vecchia University of Milan

2,988 works243,366 citationsh-index: 188

Recent Research

An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins

M. Evans,Jennifer R. Ribeiro,et al.

20261 citations

Lung Cancer Treatments and Mutations

Immunotherapy and Immune Responses

Cancer Genomics and Diagnostics

Myeloproliferative Neoplasms: Diagnosis and Treatment

CAR-T cell therapy research

Urinary and Genital Oncology Studies

Acute Myeloid Leukemia Research

Lung Cancer Research Studies

Hepatocellular Carcinoma Treatment and Prognosis

Josep M. Llovet Icahn School of Medicine at Mount Sinai

791 works153,658 citationsh-index: 151

Farhad Islami American Cancer Society

402 works122,531 citationsh-index: 96

James P. Allison Microsoft Research (United Kingdom)

1,204 works119,463 citationsh-index: 157

Paolo Boffetta University of Bologna

2,077 works112,579 citationsh-index: 167

Adolfo Garcı́a-Sastre Office of Infectious Diseases

1,142 works103,829 citationsh-index: 161

Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study

Gil Shamai,Shachar Cohen,et al.

20260 citations

TROPION-Urothelial03: A phase 2/3 study of datopotamab deruxtecan (Dato-DXd) + platinum chemotherapy (CT) vs gemcitabine + platinum CT in participants with locally advanced or metastatic urothelial carcinoma (la/mUC) with progression on or after enfortumab vedotin (EV) + pembrolizumab (pembro).

Matthew D. Galsky,Alexandra Drakaki,et al.

20260 citations

RC48G001: A phase 2 study of disitamab vedotin in HER2-expressing previously treated advanced UC.

T. Powles,Vadim S Koshkin,et al.

20260 citations

IZABRIGHT-Bladder01: A randomized, open-label, phase 2/3 trial of izalontamab brengitecan (iza-bren; BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC), vs platinum-based chemotherapy (PBC) for patients (pts) with advanced urothelial cancer (aUC) and disease progression on or after immunotherapy.

Thomas Powles,Jonathan E. Rosenberg,et al.

20260 citations

[ <sup>225</sup> Ac]Ac-AKY-1189, a Nectin-4 targeted radiopharmaceutical, in patients with previously treated locally advanced or metastatic solid tumors: Phase 1b Nectinium-2 study.

T. A. Yap,Omar Alhalabi,et al.

20260 citations